Methods to specifically profile protease activity at lymph nodes
In some aspects, the disclosure provides compositions and methods for detecting and
monitoring the activity of pro teases in vivo using affinity assays. The disclosure relates, in …
monitoring the activity of pro teases in vivo using affinity assays. The disclosure relates, in …
Methods to spatially profile protease activity in tissue and sections
Aspects of the disclosure relate to methods and composi tions useful for in vivo and/or in
vitro enzyme profiling. In some embodiments, the disclosure provides methods of in vivo …
vitro enzyme profiling. In some embodiments, the disclosure provides methods of in vivo …
Methods and products for in vivo enzyme profiling
The present invention relates to methods and products associated with in vivo enzyme
profiling. In particular, the invention relates to methods of in vivo processing of exogenous …
profiling. In particular, the invention relates to methods of in vivo processing of exogenous …
Methods and products for in vivo enzyme profiling
US11549951B2 - Methods and products for in vivo enzyme profiling - Google Patents
US11549951B2 - Methods and products for in vivo enzyme profiling - Google Patents …
US11549951B2 - Methods and products for in vivo enzyme profiling - Google Patents …
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (FOLR1)
HD Agnew, A Eliasen, BT Lai - US Patent 11,733,246, 2023 - Google Patents
The present application provides stable heterobiligands made up of peptide-based FOLR1
ligands and folate (the ligand of FOLR1) and methods of use of the heterobiligands as …
ligands and folate (the ligand of FOLR1) and methods of use of the heterobiligands as …
Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
The present application provides stable peptide-based Botulinum neurotoxin (BoNT)
serotype A capture agents and methods of use as detection and diagnosis agents and in the …
serotype A capture agents and methods of use as detection and diagnosis agents and in the …
Affinity-based detection of ligand-encoded synthetic biomarkers
5,500, 161 A 3/1996 Andrianov et al. 5,811.252 A 9/1998 Verheijen 5,885,775 A 3/1999 Haff
et¿ 1, 6,312.390 B1 11/2001 Phillips 6335429 B1 1/2002 Cai et al. 6339069 B1 1/2002 …
et¿ 1, 6,312.390 B1 11/2001 Phillips 6335429 B1 1/2002 Cai et al. 6339069 B1 1/2002 …
IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making
H Agnew, BT Lai, SM Pitram, B Farrow… - US Patent …, 2023 - Google Patents
US11719705B2 - IL-17F and IL-17A-specific capture agents, compositions, and methods of
using and making - Google Patents US11719705B2 - IL-17F and IL-17A-specific capture …
using and making - Google Patents US11719705B2 - IL-17F and IL-17A-specific capture …
Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
BT Lai, HD Agnew - US Patent 11,884,707, 2024 - Google Patents
US11884707B2 - Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase
1 (IDO1) and methods of making and using same - Google Patents US11884707B2 …
1 (IDO1) and methods of making and using same - Google Patents US11884707B2 …